All
Delving into Subcutaneous Versus Intravenous Opdivo in Solid Tumors
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors.
Always Bring a Second Set of Ears to Your Oncology Checkup!
At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling overwhelmed and alone.
HIPEC May Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer
Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.
SBRT May Be a Viable Option for Patients With Liver Cancer
CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.
The Gift of a Second Chance After My Stem Cell Transplant
After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.
FDA Grants Fast Track Designation for Abenacianine in Lung Cancer Surgery
The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally invasive surgery.
A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.
The Impact of Yescarta on Long Term Quality of Life in R/R Follicular Lymphoma
Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.
P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
Learning to ‘Let it Be’ After Poor Test Results
When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.
Peter Yarrow Dies of Bladder Cancer, Dick Vitale Cleared for ESPN Return and More
From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, here is this week’s news.
First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer
For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with relapsed/refractory osteosarcoma.
Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs
Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.
A New Year, A New Approach to Survivorship After Cancer
As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and my hopes for the future.
Minoxidil May Safely Aid in Hair Growth for Patients With Breast Cancer
Low-dose oral minoxidil, the hair growth drug that is the active ingredient in Rogaine, may be safe and effective for patients with breast cancer.
Real-World Data May Support Opdivo Plus Yervoy Efficacy in mRCC
Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.
Rybrevant Plus Lazcluze Improves Survival for EGFR+ NSCLC
First-line Rybrevant plus Lazcluze improved survival versus the current standard of care in patients with mutated advanced or metastatic NSCLC.
Understanding the Benefit of Subcutaneous Versus IV Opdivo in Patients With Solid Tumors
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors.
My Top 10 Hacks for Surviving with Cancer in the Infusion Room
Every treatment bag should include an unlimited supply of humor. Stuff will happen. It’ll be hard, but you may learn to laugh about it later, like I did.
Psilocybin May Have Mental Health Benefits for Patients With Cancer
CURE spoke with an expert about the potential positive effects of psilocybin-assisted psychotherapy.
BLA Has Been Submitted For Kidney Cancer Imaging PET Product Zircaix
A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.
Retiring Shouldn’t Mean Resigning: The Power of Speaking Up About Your Advanced Prostate Cancer Treatment Options
Coming to Terms With Hair Loss After Chemotherapy
Losing my hair after chemo was devastating, and I struggled to accept how it changed my appearance and self-image.
Stereotactic Body Radiation May Improve Survival in Liver Cancer Subset
Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in locally advanced hepatocellular carcinoma.
A Year of Resilience: Looking Back After a Myeloma Diagnosis
2024 was a year of resilience after a myeloma diagnosis, marked by a return to public speaking, a documentary filming experience and a fundraising walk.
CBD Use Found to Be Safe Among Patients with Breast Cancer, Prompts Further Study
CBD consumption was safe but did not have a statistically significant reduction in scan-related anxiety versus placebo for patients with breast cancer.
Short-Course Radiation Aids Survival in Older Patients With Glioblastoma
18F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly diagnosed glioblastoma.
Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic malignancies.
Cisplatin-Based Chemo Regimen May Improve Survival in Bladder Cancer
Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder cancer.